Suppression of matrix metalloproteinase-9 by prostaglandin E2 in peritoneal macrophage is associated with severity of endometriosis

American Journal of Pathology

Volumn 167, Issue 4, 2005, Pages 1061-1069

  Wu, Meng Hsing ^a   Shoji, Yutaka ^a   Wu, Meng Chi ^a   Chuang, Pei Chin ^a   Lin, Chen Chung ^a   Huang, Mei Feng ^a   Tsai, Shaw Jenq ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GELATINASE B; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROTEIN; REVERSION INDUCING CYSTEINE RICH PROTEIN WITH KAZAL MOTIFS; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIOSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PERITONEAL FLUID; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 26244436313     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61195-9     Document Type: Article

References (44)

1. Sampson JA: Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927, 14:422-425
2. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S: Estrogen production and metabolism in endometriosis. Ann NY Acad Sci 2002, 955:75-85
3. Tsai SJ, Wu MH, Lin CC, Sun HS, Chen SM: Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab 2001, 86:5765-5773
4. Dmowski WP, Braun D, Gebel H: Endometriosis: genetic and immunologic aspects. Prog Clin Biol Res 1990, 323:99-122
5. Dmowski WP, Gebel HM, Braun DP: The role of cell-mediated immunity in pathogenesis of endometriosis. Acta Obstet Gynecol Scand Suppl 1994, 159:7-14
6. Dunselman GA, Hendrix MG, Bouckaert PX, Evers JL: Functional aspects of peritoneal macrophages in endometriosis of women. J Reprod Fertil 1988, 82:707-710
7. Haney AF, Muscato JJ, Weinberg JB: Peritoneal fluid cell populations in infertility patients. Fertil Steril 1981, 35:696-698
8. Raiter-Tenenbaum A, Baranao RI, Etchepareborda JJ, Meresman GF. Rumi LS: Functional and phenotypic alterations in peritoneal macrophages from patients with early and advanced endometriosis. Arch Gynecol Obstet 1998, 261:147-157
9. Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839
10. Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F, Docherty AJ: Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 1994, 269:6632-6636
11. Shipley JM, Doyle GA, Fliszar CJ, Ye QZ, Johnson LL, Shapiro SD, Welgus HG, Senior RM: The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 1996, 271:4335-4341
12. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J: Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001, 69:851-859
13. Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M: Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001, 75:152-159
14. Szamatowicz J, Laudanski P, Tomaszewska I: Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum Reprod 2002, 17:284-288
15. Collette T, Bellehumeur C, Kats R, Maheux R, Mailloux J, Villeneuve M, Akoum A: Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 2004, 19:1257-1264
16. Dhami R, Gilks B, Xie C, Zay K, Wright JL, Churg A: Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by alpha1-antitrypsin. Am J Respir Cell Mol Biol 2000, 22:244-252
17. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW: Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998, 102:1900-1910
18. Campbell EJ, Cury JD, Shapiro SD, Goldberg GI, Welgus HG: Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol 1991, 146:1286-1293
19. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg GI: Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest 1990, 86:1496-1502
20. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW: Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000, 105:1641-1649
21. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Senior RM, Ivan E: Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002, 91:852-859
22. Ratzinger G, Stoitzner P, Ebner S, Lutz MB, Layton GT, Rainer C, Senior RM, Shipley JM, Fritsch P, Schuler G, Romani N: Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol 2002, 168:4361-4371
23. McMillan JI, Weeks R, West JW, Bursten S, Rice GC, Lovett DH: Pharmacological inhibition of gelatinase B induction and tumor cell invasion. Int J Cancer 1996, 67:523-531
24. Habu Y, Fukada-Tanaka S, Hisatomi Y, Iida S: Amplified restriction fragment length polymorphism-based mRNA fingerprinting using a single restriction enzyme that recognizes a 4-bp sequence. Biochem Biophys Res Commun 1997, 234:516-521
25. Wu MH, Sun HS, Lin CC, Hsiao KY, Chuang PC, Pan HA, Tsai SJ: Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis. Mol Hum Reprod 2002, 8:1103-1110
26. Wu MH, Wang CA, Lin CC, Chen LC, Chang WC, Tsai SJ: Distinct regulation of cyclooxygenase-2 by interleukin-1beta in normal and endometriotic stromal cells. J Clin Endocrinol Metab 2005, 90:286-295
27. ASRM: The American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis:1996. Fertil Steril 1997, 67:817-821
28. Ma Z, Qin H, Benveniste EN: Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J Immunol 2001, 167:5150-5159
29. 2α resistance or susceptibility in human granulosa-luteal cells. Mol Hum Reprod 2001, 7:415-423
30. Sun HS, Hsiao KY, Hsu CC, Wu MH, Tsai SJ: Transactivation of steroidogenic acute regulatory protein in human endometriotic stromal cells is mediated by the prostaglandin EP2 receptor. Endocrinology 2003, 144:3934-3942
31. Curry Jr TE, Osteen KG: The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 2003, 24:428-465
32. Rhee JS, Coussens LM: RECKing MMP function: implications for cancer development. Trends Cell Biol 2002, 12:209-211
33. Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C: RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 2003, 22:167-175
34. Cheong YC, Shelton JB, Laird SM, Richmond M, Kudesia G, Li TC, Ledger WL: IL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions. Hum Reprod 2002, 17:69-75
35. Keenan JA, Chen TT, Chadwell NL, Torry DS, Caudle MR: IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Imunol 1995, 34:381-385
36. Wu MH, Chuang PC, Chen SM, Lin CC, Tsai SJ: Increased leptin expression in endometriosis cells is associated with endometrial stromal cell proliferation and leptin gene-upregulation. Mol Hum Reprod 2002, 8:456-464
37. Lord G: Role of leptin in immunology. Nutr Rev 2002, 60:S35-S85
38. Sanceau J, Boyd DD, Seiki M, Bauvois B: Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B. J Biol Chem 2002, 277:35766-35775
39. Yoo HG, Shin BA, Park JS, Lee KH, Chay KO, Yang SY, Ahn BW, Jung YD: IL-1 beta induces MMP-9 via reactive oxygen species and NF-kappaB in murine macrophage RAW 264.7 cells. Biochem Biophys Res Commun 2002, 298:251-256
40. Xie B, Dong Z, Fidler IJ: Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J Immunol 1994, 152:3637-3644
41. Dawood MY, Khan-Dawood FS, Wilson Jr L: Peritoneal fluid prostaglandins and prostanoids in women with endometriosis, chronic pelvic inflammatory disease, and pelvic pain. Am J Obstet Gynecol 1984, 148:391-395
42. Ruwanpura SM, Noguchi K, Ishikawa I: Prostaglandin E2 regulates interleukin-1 beta-induced matrix metalloproteinase-3 production in human gingival fibroblasts. J Dent Res 2004, 83:260-265
43. Breyer RM, Bagdassarian CK, Myers SA, Breyer MD: Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001, 41:661-690
44. Galis ZS, Khatri JJ: Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002, 90:251-262